 |
|
Olfactory NeuroblastomaBiologic and Clinical Behavior
Kerry D. Olsen, MD;
Lawrence W. DeSanto, MD
Arch Otolaryngol. 1983;109(12):797-802.
Abstract
• The biologic behavior of olfactory neuroblastoma in 21 persons treated at the Mayo Clinic, Rochester, Minn, from 1960 to 1980 is reviewed. Follow-up data of five years or more are available for 19 cases. Findings showed the tendency of these tumors to spread submucosally and intracranially without obvious involvement of the anterior cranial fossa dura. The aggressive nature of this lesion has not been appreciated. Metastatic disease occurred in 62% and local recurrence in 57%. Long-term follow-up showed that recurrent or metastatic disease could occur up to ten years after initial diagnosis. The five-year survival rate was 58%. Only four patients who have been follow-up for more than five years were without local recurrence or metastasis. This review should prompt a change in the current attitudes toward treatment of this tumor.
(Arch Otolaryngol 1983;109:797-802)
Author Affiliations
From the Department of Otorhinolaryngology, Mayo Clinic and Mayo Foundation, Rochester, Minn.
Footnotes
Accepted for publication April 18, 1983.
Read before the American Society for Head and Neck Surgery, Palm Springs, Calif, March 11, 1983.
Reprint requests to Department of Otorhinolaryngology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905 (Dr Olsen).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Radiology Quiz Case 3: Diagnosis
Arch Otolaryngol Head Neck Surg 2005;131:927-927.
FULL TEXT
Chronic Syndrome of Inappropriate Antidiuretic Hormone Secretion and Hypertension in a Patient With Olfactory Neuroblastoma: Evidence of Ectopic Production of Arginine Vasopressin by the Tumor
Osterman et al.
Arch Intern Med 1986;146:1731-1735.
ABSTRACT
Olfactory Neuroblastoma: Chemotherapy and Radiotherapy for Extensive Disease
Weiden et al.
Arch Otolaryngol Head Neck Surg 1984;110:759-760.
ABSTRACT
|
